Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Cangene Corporation

Below is an extended Cangene Corporation research listing. Click here to return to the Cangene Corporation main Biocorporate entry.

Recent Publications by Cangene Corporation:

Pathogen safety of intravenous Rh immunoglobulin liquid and other immune globulin products: enhanced nanofiltration and manufacturing process overview.
Plasma products for therapeutic use pose specific challenges in...
5th November, 2008
Product Development, Cangene Corporation, Winnipeg, Manitoba, Canada. Am J Ther. 2008 Sep-Oct;15(5):435-43.
DOI Direct Link
Comparative pharmacokinetics of liquid and lyophilized formulations of IV RhIG immune globulin.
To compare the pharmacokinetics, safety, and tolerability of the liquid...
15th October, 2008
Cangene Corporation, Medical Affairs, 155 Innovation Drive, Winnipeg, Biologicals. 2008 Jul;36(4):256-62. Epub 2008 Apr 10.
DOI Direct Link
Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor.
ABSTRACT Conjugates of recombinant human granulocyte-macrophage...
15th April, 2008
Cangene Corporation, Mississauga, ON, Canada M9W 6A9. J Interferon Cytokine Res. 2008 Feb;28(2):101-12.
DOI Direct Link
Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
Burkholderia pseudomallei is a biothreat agent and an important natural...
4th April, 2008
Cangene Corporation, Mississauga, ON, Canada. FEMS Immunol Med Microbiol. 2008 Jan;52(1):78-87. Epub 2007 Nov 11.
DOI Direct Link
On the influence of vector design on antibody phage display.
Phage display technology is an established technology particularly useful...
23rd March, 2007
Cangene Corporation, 3403 American Drive, Mississauga, Ontario L4V 1T4, J Biotechnol. 2007 Jan 20;127(4):626-37. Epub 2006 Sep 22.
DOI Direct Link
Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein.
The cynomolgus macaque, Macaca fascicularis, is frequently used in...
21st January, 2006
Cangene Corporation, 3404 American Drive, Mississauga, Ontario L4V 1T4, Immunogenetics. 2005 Nov;57(10):730-8. Epub 2005 Nov 8.
DOI Direct Link
Purification and characterization of recombinant Streptomyces griseus aminopeptidase.
Recombinant Streptomyces griseus aminopeptidase (SGAP) was produced using...
12th February, 2004
Department of Biotechnology Research, Cangene Corporation, Mississauga, Protein Expr Purif. 2003 Jul;30(1):62-8.
A new helper phage and phagemid vector system improves viral display of antibody Fab fragments and avoids propagation of insert-less virions.
Phage display technology (PDT) is a powerful method for isolating...
10th April, 2003
Cangene Corporation, 3403 American Drive, L4V 1T4, Mississauga, Ontario, J Immunol Methods. 2003 Mar 1;274(1-2):233-44.

«Cangene Corporation

This page contained an extended Cangene Corporation research listing. Click here to return to the Cangene Corporation main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.